T type 1/type 2 subsets balance in B-cell chronic lymphocytic leukemia--the three-color flow cytometry analysis

Monika Podhorecka1, Anna Dmoszynska, Jacek Rolinski

  • 1Department of Clinical Immunology, University School of Medicine in Lublin, Jaczewskiego 8, 20-950, Lublin, Poland. mpodhor@asklepios.am.lukin.pl

Leukemia Research
|May 15, 2002
PubMed

Insights

Immune cell imbalances in B-cell chronic lymphocytic leukemia (B-CLL) shift towards T type 2 during disease progression. This study evaluated T-helper (Th) and T-cytotoxic (Tc) cell balance in B-CLL patients.

Area of Science:

  • Immunology
  • Hematology
  • Oncology

Background:

  • B-cell chronic lymphocytic leukemia (B-CLL) is characterized by immune cell dysfunction and secondary immune deficiencies.
  • Understanding the T-cell balance is crucial for comprehending B-CLL pathogenesis.

Purpose of the Study:

  • To evaluate the Th1/Th2 and Tc1/Tc2 balance in B-CLL patients compared to healthy individuals.
  • To investigate how this balance changes during B-CLL disease progression.

Main Methods:

  • Utilized three-color flow cytometry to analyze cytokine expression (IL-4, IFN-gamma).
  • Assessed cytokine expression in peripheral blood CD3+CD4+ (T-helper) and CD3+CD8+ (T-cytotoxic) cells.

Main Results:

  • B-CLL patients exhibit a dominance of T type 1 cells, indicating T-cell-mediated immunity.
  • A shift towards T type 2 cells was observed as the disease progresses in B-CLL patients.

Conclusions:

  • The T-cell immune response in B-CLL is initially T type 1 dominant but shifts towards T type 2 during disease progression.
  • These findings contribute to understanding immune dysregulation in B-CLL.